ImmunoGen Inc.

(IMGN) Trade

By |

Profile

Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.

Contact Information

Website: www.immunogen.com
Email: info@immunogen.com
Main Phone: +1 781 895-0600
Address: 830 Winter Street
State: MA
City / Town: Waltham
Country: USA
Postal Code: 02451

Issuer Information

Exchange: NGS
CEO: Mark J. Enyedy
Employees: 293
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 10.25 $ 0.28 (2.81%)
Last Price 10.25 Change $ 0.28 Change % 2.81 Tick N/A
Bid 9.95 Bid Size 200.00 Ask 10.89 Ask Size 100.00
Open 10.00 High 10.37 Low 9.95 Prev Close 9.97
Last Trade Volume 2.9 mi 52 Wk Hi 13.41 52 Wk Low 4.80
Market Cap 1.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 146,736,946.00 EPS (TTM) -1.06 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 4 28
Number of Buys 2 9
Number of Sells 2 19
Net Activity 0 -169562
Last 10 Buys Shares
Mark A. Goldberg 1,000
Mark J. Enyedy 1,000
John M. Lambert 1,000
David Johnston 1,000
Richard J. Gregory 1,000
Craig Barrows 1,000
Dean Jonathan Mitchell 1,000
Mark A. Goldberg 1,000
Last 10 Sell Shares
David Johnston 1,000
Daniel M. Junius 1,000
David Johnston 1,000
Daniel M. Junius 1,000
David Johnston 1,000
Thomas Ryll 1,000
Theresa Wingrove 1,000
Richard J. Gregory 1,000
Mark J. Enyedy 1,000
Anna Berkenblit 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 18 18
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 10.75 10.63 10.63 10.75
Standard Deviation 5.23 5.13 5.13 5.23
Date of Most Recent Estimate 06/03/18 05/15/18 05/15/18 06/13/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.03 2.03 2.03 2.03